• Korean
  • Chinese
表紙
市場調査レポート - 242196

ベトナムにおける医薬品市場

The Pharmaceutical Market: Vietnam

発行 Espicom Business Intelligence
出版日 ページ情報 英文 110 pages
価格
ベトナムにおける医薬品市場 The Pharmaceutical Market: Vietnam
出版日: 2013年01月31日 ページ情報: 英文 110 pages
担当者のコメント
このシリーズは、他にも調査対象国がございます。詳細はお問合せください。
概要

当レポートでは、ベトナムの医薬品市場について、市場全体の動向と法規制、 医薬品流通チャネルなどを分析し、OTC医薬品、ジェネリック医薬品、 バイオ医薬品・バイオシミラーなどのセグメント別の動向、市場の機会と課題などを併せ、 概略下記の構成でお届けいたします。

目次

エグゼクティブサマリー

  • スナップショット: Espicom の戦略的分析
  • スナップショット: 主要データ予測

マクロ環境

  • 政治環境
  • 経済環境
  • 法環境
  • 人口統計

疫学

  • 病気の負荷
  • 羅漢率

ヘルスケア - 保健統計付

  • 組織・機構
  • 医療費
    • インフラストラクチャー
  • 労働力

規制関連情報

  • 国際機関
  • 国内当局 & 規制
  • 製造管理および品質管理に関する基準
  • 市場登録
    • 標識付け
  • 広告・宣伝

価格決定および償還

  • 価格決定
  • 償還

流通チャネル

  • 医薬品 卸売り
  • 医薬品 小売

市場分析

  • 規模
  • 製品開発
  • 製造
  • 貿易

競合状況

  • 事業者団体
  • 見本市
  • 企業情報

OTC 医薬品

  • 市場
  • 競合状況

ジェネリック医薬品

  • 市場
  • 競合状況

生物製剤/バイオシミラー

  • 調査 & 開発
  • 競合状況

結び: 機会と課題

  • Espicom の戦略的分析
  • レーダー解析
  • SWOT分析

関係各機関・組織一覧

  • 政府組織
  • 製薬会社
  • 医薬品卸売り業者
  • 薬局チェーン
  • 事業者団体

調査方法および情報ソース

図表


このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Abstract

Summary

Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context.

The reports provide:

  • Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
  • Specialised intelligence on OTCs, generics, biologics and biosimilars.
  • Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
  • A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.

The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.

Description

THE PHARMACEUTICAL MARKET: VIETNAM - REVIEW

The macroenvironment is positive for Vietnam's pharmaceutical market growth, despite concerns over IPR. Economically, the Economist Intelligence Unit projects Vietnam's GDP to be one of the smallest in the Asia Pacific region by 2016, ranked 15th. Legally, despite Vietnam remaining on the USTR Special 301 Watch List in 2011, the USA is encouraged by the government's attempts to improve IPR protection and its enforcement; particularly of note are recent amendments to the IP Law. Demographically, Vietnam has a large and young population, which will be the eighth largest population in the Asia Pacific region by 2016. The elderly population is rising, albeit slowly, and will remain one of the lowest proportions in the Asia Pacific region.

The Drug Administration of Vietnam (DAV) has warned that drug prices could rise slightly in 2011 due to volatile raw material prices and the VND-US$ exchange rate. The Vietnam Pharmaceutical Companies Association (VNPCA) forecasts higher sales prices for both imported and domestic drugs in 2011, due to higher input costs and rising world prices. To review the local pharmaceutical market and prevent large drug price increases, the DAV has announced several measures. Accordingly, the DAV will step-up the inspection of drug price quotations by pharmaceutical companies through health workgroups and will promptly publish the results. The DAV will also supervise the enforcement of state regulations on drug price management and exercise sanctions on violators.

Rising drug consumption and government investment make Vietnam an attractive pharmaceutical market. Drug consumption in per capita terms is expected to increase by around 70% in 2014. In terms of output, Espicom estimates that pharmaceutical production has increased by a CAGR of over 25% during the period 2005 to 2010. The government has announced that improving the domestic pharmaceutical industry is the health sector's highest priority over the next few years. A plan to develop and restructure Vietnam's pharmaceutical industry is underway, which includes boosting the production of essential drugs in order to cut prices, stabilise the market and reduce the country's dependence on foreign pharmaceutical imports.

ENHANCED STRATEGIC INTELLIGENCE

Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context.

The reports provide:

  • Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
  • Specialised intelligence on OTCs, generics, biologics and biosimilars.
  • Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
  • A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.

The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.

HEALTHCARE STATISTICS

A comprehensive tabula review, comprising demographics, epidemiology, health expenditure, hospital and primary care infrastructure & services and healthcare personnel, is additionally included.

About Espicom Business Intelligence

Espicom Business Intelligence is a UK-based company with a 30-year pedigree providing business intelligence on Medical Devices, Pharmaceuticals & Healthcare and Therapeutics across global markets.

Table of Contents

Executive Summary

SWOT Analysis

  • Vietnam Pharmaceutical And Healthcare Industry SWOT
  • Vietnam Political SWOT
  • Vietnam Economic SWOT
  • Vietnam Business Environment SWOT

Pharmaceutical Risk/Reward Ratings

  • Table: Asia Pacific Pharmaceutical Risk/Reward Ratings, Q113
  • Rewards
  • Risks

Vietnam - Market Summary

Regulatory Regime

  • Pharmaceutical Advertising
  • Intellectual Property Environment
  • IP Shortcomings
  • Counterfeit Drugs
  • Corruption
  • Pricing Regime
  • Price Spikes
  • Reimbursement Regime
  • Pricing And Reimbursement Developments

Industry Trends And Developments

  • Epidemiology
  • Communicable Diseases
  • HIV/AIDS
  • Non-Communicable Diseases
  • Healthcare Financing
  • Hospital Sector
  • Private Healthcare Sector
  • Healthcare Insurance
  • Healthcare And Pharmaceutical Reform
  • Foreign Partnerships
  • Research & Development
  • Biotechnology Sector
  • Vaccines
  • Clinical Trials
  • Medical Device Market

Industry Forecast Scenario

  • Overall Market Forecast
    • Table: Pharmaceutical Sales Indicators 2008-2016
  • Healthcare Market Forecast
    • Table: Healthcare Expenditure Indicators 2008-2016
    • Table: Healthcare Governmental Indicators 2008-2016
    • Table: Healthcare Private Indicators 2008-2016
  • Key Growth Factors - Macroeconomic
    • Table: Vietnam - Economic Activity
  • Prescription Drug Market Forecast
    • Table: Prescription Drug Sales Indicators 2008-2016
  • Patented Drug Market Forecast
    • Table: Patented Drug Market Indicators 2008-2016
  • Generic Drug Market Forecast
    • Table: Generic Drug Sales Indicators 2008-2016
  • OTC Medicine Market Forecast
    • Table: OTC Medicine Sales Indicators 2008-2016
  • Pharmaceutical Trade Forecast
    • Table: Exports and Imports Indicators 2008-2016
  • Medical Device Market Forecast
    • Table: Medical Devices Sales Indicators 2008-2016
  • Other Healthcare Data Forecasts
  • Key Risks To BMI's Forecast Scenario

Competitive Landscape

  • Pharmaceutical Industry
  • Domestic Pharmaceutical Sector
  • Foreign Pharmaceutical Sector
  • Recent Pharmaceutical Industry News
  • Traditional Medicines
  • Pharmaceutical Distribution
  • Pharmaceutical Retail Sector
    • Table: Key Aspects Of Good Pharmacy Practice In Developing Countries

Company Profiles

  • Local Companies
  • Vietnam Pharmaceutical Corporation (Vinapharm)
  • Vietnam OPV Pharmaceutical Co
  • Vietnam Pharmaceutical Joint Stock Company (Ampharco)
  • Vidipha Central Pharmaceutical Joint Stock Company
  • Multinational Companies
  • Pfizer
  • Sanofi
  • Novartis
  • Merck & Co
  • GlaxoSmithKline

Vietnam Demographic Outlook

  • Table: Vietnam's Population By Age Group, 1990-2020 (‘000)
  • Table: Vietnam's Population By Age Group, 1990-2020 (% of total)
  • Table: Vietnam's Key Population Ratios, 1990-2020
  • Table: Vietnam's Rural And Urban Population, 1990-2020

Glossary

BMI Methodology

  • How We Generate Our Pharmaceutical Industry Forecasts
  • Pharmaceuticals Risk/Reward Ratings Methodology
  • Ratings Overview
    • Table: Pharmaceutical Business Environment Indicators
  • Weighting
    • Table: Weighting Of Components
  • Sources
Back to Top